title: Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions.
abstract: Renal hyperplasia and hypertrophy are early events after nephron reduction which precede progressive destruction of the remnant kidney. Restriction of dietary sodium content was shown to reduce renal lesions following nephron reduction. AP-1 is a transcription factor, resulting from heterodimerization of fos and jun proteins, which mediates the effects of mitogenic growth factors. To elucidate the role of AP-1 in growth processes involved in renal deterioration, we evaluated whether restriction of dietary sodium content (0.25 vs. 0.50% sodium w/w) affected AP-1-DNA binding and hyperplasia in the remnant kidney after nephron reduction (70% nephrectomy). Cell proliferation, evaluated by PCNA immunostaining, increased progressively from day 7 to day 60 in glomeruli, proximal and distal tubules and loops of Henle of nephrectomized (Nx) rats compared to control sham-operated (C) animals. AP-1-DNA binding activity increased 7 and 14 days after surgery, but it was reduced below C values at day 60. c-fos and c-jun expression were also reduced in Nx rats at day 60. Sodium restriction significantly reduced the number of PCNA-stained cells in glomeruli and tubules at days 14 and 60, but not at day 7, whereas it decreased AP-1 activation at all times of the study. This effect was associated to a marked reduction of renal lesions in Nx rats. In conclusion, we showed that, after nephron reduction, the beneficial effect of sodium restriction was associated with a reduction of hyperplasia and AP-1 activation, but that the latter did not parallel delayed cell proliferation rate in remaining nephrons. Thus, we propose that different transduction pathways are involved in cell proliferation after nephron reduction, according to the time of evolution of renal lesions.
authors.affiliation: INSERM U426 et Département de Physiologie, Faculté Xavier Bichat, Paris, France. terzi@cochin.inserm.fr
authors.forename: F
authors.initials: F
authors.lastname: Terzi
authors.forename: M
authors.initials: M
authors.lastname: Burtin
authors.forename: M
authors.initials: M
authors.lastname: Hekmati
authors.forename: C
authors.initials: C
authors.lastname: Jouanneau
authors.forename: H
authors.initials: H
authors.lastname: Beaufils
authors.forename: G
authors.initials: G
authors.lastname: Friedlander
mesh_terms: D000818:Animals; D002455:Cell Division; D004247:DNA / Q000378:metabolism; D004039:Diet, Sodium-Restricted; D015870:Gene Expression; D016762:Genes, fos / Q000235:genetics; D016758:Genes, jun / Q000235:genetics; D006965:Hyperplasia; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D007674:Kidney Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D009392:Nephrectomy; D009399:Nephrons / Q000473:pathology*; D009929:Organ Size; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D018808:Transcription Factor AP-1 / Q000378:metabolism*
chemical_list: D018809:Proliferating Cell Nuclear Antigen; D018808:Transcription Factor AP-1; D004247:DNA